Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1441-1450 of 3399 for cancer

Edit search filters
  1. Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients with Pancreatic Cancer That Has Been Removed by Surgery

    Jacksonville, FL, Rochester, MN

  2. A Study Of Tyrosine Kinase Inhibitor ICP-022 In Patients With R/r B-Cell Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  4. A Study To Evaluate RP1 Monotherapy And Combined With Nivolumab

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Focal MR-Guided Focused Ultrasound Treatment Of Localized Intermediate Risk Prostate Lesions

    Rochester, MN

  6. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

    Rochester, MN

  7. An Open-label Study Using ASP-1929 Photoimmunotherapy In Combination With Anti-PD1 Therapy In EGFR Expressing Advanced Solid Tumors

    Rochester, MN

  8. Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other Myelodysplastic /Myeloproliferative Neoplasias, and Acute Myeloid Leukemia

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN, Mankato, MN, Eau Claire, WI

  10. Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer